(Q79319913)

English

Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka

scientific article published on 01 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Momordica charantia

1 reference

(2R,3R,4S,5S,6R)-2-[(4S,5S,6S)-5-hydroxy-6-[(3S,7S,8R,9S,10S,13R,14S,17R)-3-hydroxy-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-en-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12R,13S,16S)-8-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

2-(Hydroxymethyl)-6-[[8-(6-methoxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

(3S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-17-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(3S,7R,8R,9S,10S,13R,14S,17R)-17-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12R,13S,16S)-8-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12S,13S,16S,19R)-19-methoxy-8-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

(19R,23E)-3beta-(beta-D-Allopyranosyloxy)-5beta,19-epoxy-19,25-dimethoxycucurbita-6,23-diene

1 reference

(2R,3R,4S,5S,6R)-2-[(4S,5R,6S)-5-hydroxy-6-[(3S,7R,8R,9S,10S,13R,14S,17R)-3-hydroxy-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-en-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

1 reference

Karavilagenin C

1 reference

7-methoxy-17-(6-methoxy-6-methylhept-4-en-2-yl)-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

8-(6-Hydroxy-6-methylhept-4-en-2-yl)-19-methoxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

Karaviloside II

1 reference

(1S,4S,5S,8R,9R,12S,13S,16R)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

Momordicoside I

1 reference

(1S,4S,5S,8R,9R,12S,13S,16S,19R)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-19-methoxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(3S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-17-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,7S,8R,9S,10S,13R,14S,17R)-7-methoxy-17-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

1 reference

momordicoside F1

1 reference

Karavilagenin B

1 reference

3-hydroxy-17-(6-hydroxy-6-methylhept-4-en-2-yl)-4,4,13,14-tetramethyl-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde

1 reference

(1R,3aS,3bR,4S,7S,9aS,9bS,11aR)-4-methoxy-1-[(2R,4E)-6-methoxy-6-methylhept-4-en-2-yl]-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3bH,4H,7H,8H,9H,9aH,10H,11H-cyclopenta[a]phenanthren-7-ol

1 reference

(3S,7R,8R,9S,10S,13R,14S,17R)-17-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

2-(Hydroxymethyl)-6-[[8-(6-hydroxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

BOHOBTRHAFBJOW-RWMRUTBJSA-N

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12S,13S,16S)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

NFGQKKGYMKRYEF-MZQKGWIASA-N

1 reference

(1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-ol

1 reference

1 reference

(19R)-19-Methoxy-5beta,19-epoxycucurbita-6,23-diene-3beta,25-diol

1 reference

momordicoside F2

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12S,13S,16S)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

8-(6-Hydroxy-6-methylhept-4-en-2-yl)-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-ol

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(3S,7R,8R,9S,10S,13R,14S,17R)-7-methoxy-17-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol

1 reference

3-hydroxy-17-(6-methoxy-6-methylhept-4-en-2-yl)-4,4,13,14-tetramethyl-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-9-carbaldehyde

1 reference

HPSVQEWDZSDXRG-FCNDEKGWSA-N

1 reference

(3S,7R,8R,9S,10S,13R,14S,17R)-17-[(2R,4R)-4-hydroxy-6-methylhept-5-en-2-yl]-7-methoxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol

1 reference

19-Norlanosta-6,23-diene-9-carboxaldehyde, 3-(beta-D-glucopyranosyloxy)-5-hydroxy-25-methoxy-, cyclic (9R)-9,5-(methyl acetal), (3beta,5beta,9beta,10alpha,23E)-

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12S,13S,16S,19R)-19-methoxy-8-[(E,2R)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

(2R,3S,4R,5R,6R)-2-(hydroxymethyl)-6-{[(1R,4S,5S,8R,9R,12S,13S,16S)-8-[(2R,4E)-6-methoxy-6-methylhept-4-en-2-yl]-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.0¹,¹³.0⁴,¹².0⁵,⁹]nonadec-2-en-16-yl]oxy}oxane-3,4,5-triol

1 reference

Karaviloside III

1 reference

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(1S,4S,5S,8R,9R,12S,13S,16S,19R)-8-[(E,2R)-6-hydroxy-6-methylhept-4-en-2-yl]-19-methoxy-5,9,17,17-tetramethyl-18-oxapentacyclo[10.5.2.01,13.04,12.05,9]nonadec-2-en-16-yl]oxy]oxane-3,4,5-triol

1 reference

Momordicoside K

1 reference

NFGQKKGYMKRYEF-XSBOJVAASA-N

1 reference

Goyaglycoside b

1 reference

1 reference

based on heuristic

inferred from title

1 reference

Momordica foetida

1 reference

author name string

Seikou Nakamura

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Toshiyuki Murakami

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Junko Nakamura

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hisanori Kobayashi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Hisashi Matsuda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Masayuki Yoshikawa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

1 reference

Chemical & Pharmaceutical Bulletin

publication date

2006

3 references

16 September 2022

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb/54/11/54_11_1545/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.54.1545?email=unpaywall_01@example.com

Chemical & Pharmaceutical Bulletin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1545-1550

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

online access status

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.54.1545?email=unpaywall_01@example.com

access restriction status

1 reference

based on heuristic

inferred from online access status

Medicinal Foodstuffs. XXVI. Inhibitors of Aldose Reductase and New Triterpene and Its Oligoglycoside, Centellasapogenol A and Centellasaponin A, from Centella asiatica (Gotu Kola)

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.3987/COM-01-9259

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Nigellamines A3, A4, A5, and C, new dolabellane-type diterpene alkaloids, with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.52.494

Studies on the constituents of Momordica charantia L. III. Characterization of new cucurbitacin glycosides of the immature fruits. (1). Structures of momordicosides G, F1, F2 and I.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.30.3977

New Cucurbitane Triterpenoids from Momordica charantia

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Studies on the constituents of Momordica charantia L. II. Isolation and characterization of minor seed glycosides, momordicosides C,D and E.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.29.1561

Medicinal foodstuffs. XXXI. Structures of new aromatic constituents and inhibitors of degranulation in RBL-2H3 cells from a Japanese folk medicine, the stem bark of Acer nikoense.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.51.62

Cucurbitane triterpenoids from the leaves of Momordica foetida

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Medicinal foodstuffs. XXV. Hepatoprotective principle and structures of ionone glucoside, phenethyl glycoside, and flavonol oligoglycosides from young seedpods of garden peas, Pisum sativum L.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.1003

Studies on the constituents of Momordica charantia L. I. Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.28.2753

Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.54

The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Studies on the constituents of Polygala japonica HOUTT. II. Structures of polygalasaponins XI-XIX

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.43.966

Structures of momordicines I, II and III, the bitter principles in the leaves and vines of Momordica charantia L.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.32.2044

Medicinal foodstuffs. XXIX. Potent protective effects of sesquiterpenes and curcumin from Zedoariae Rhizoma on liver injury induced by D-galactosamine/lipopolysaccharide or tumor necrosis factor-alpha

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.25.627

Medicinal foodstuffs. XXII. Structures of oleanane-type triterpene oligoglycosides, pisumsaponins I and II, and kaurane-type diterpene oligoglycosides, pisumosides A and B, from green peas, the immature seeds of Pisum sativum L.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.73

Oral hypoglycaemic activity of some medicinal plants of Sri Lanka.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

Medicinal foodstuffs. XXVIII. Inhibitors of nitric oxide production and new sesquiterpenes, zedoarofuran, 4-epicurcumenol, neocurcumenol, gajutsulactones A and B, and zedoarolides A and B, from Zedoariae Rhizoma

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.1558

Medicinal foodstuffs. XXIV. Chemical constituents of the processed leaves of Apocynum venetum L.: absolute stereostructures of apocynosides I and II.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.845

Medicinal foodstuffs. XXVII. Saponin constituents of gotu kola (2): structures of new ursane- and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.1368

Medicinal foodstuffs. XXIII. Structures of new oleanane-type triterpene oligoglycosides, basellasaponins A, B, C, and D, from the fresh aerial parts of Basella rubra L

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.1248/CPB.54.1545

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.49.776

Identifiers

10.1248/CPB.54.1545

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17077551%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79319913&oldid=2133562199"